Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Pharmacogenomics, CYP2D6, Breast Cancer

Alex Bhatt

MD

🏢Indiana University Melvin and Bren Simon Cancer Center🌐USA

Associate Professor of Breast Oncology and Pharmacogenomics

43
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Alex Bhatt investigates the impact of CYP2D6 genetic variation on tamoxifen metabolism and breast cancer outcomes. His research has characterized how CYP2D6 poor metabolizer status reduces conversion of tamoxifen to its active metabolite endoxifen, potentially compromising breast cancer treatment. He has evaluated endoxifen-based dosing strategies to achieve therapeutic plasma levels regardless of CYP2D6 genotype. His clinical research has addressed the controversial question of whether CYP2D6 testing should guide tamoxifen dosing decisions in breast cancer patients.

Share:

🧪Research Fields 研究领域

CYP2D6 variants
tamoxifen metabolism
breast cancer
endoxifen
pharmacogenomics clinical implementation

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Alex Bhatt 的研究动态

Follow Alex Bhatt's research updates

留下邮箱,当我们发布与 Alex Bhatt(Indiana University Melvin and Bren Simon Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment